Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Common Equity: 2010-2025

Historic Common Equity for Alkermes (ALKS) over the last 15 years, with Sep 2025 value amounting to $1.7 billion.

  • Alkermes' Common Equity rose 34.16% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 34.16%. This contributed to the annual value of $1.5 billion for FY2024, which is 21.81% up from last year.
  • According to the latest figures from Q3 2025, Alkermes' Common Equity is $1.7 billion, which was up 6.70% from $1.6 billion recorded in Q2 2025.
  • Alkermes' 5-year Common Equity high stood at $1.7 billion for Q3 2025, and its period low was $1.0 billion during Q1 2023.
  • Its 3-year average for Common Equity is $1.4 billion, with a median of $1.3 billion in 2024.
  • Its Common Equity has fluctuated over the past 5 years, first fell by 6.49% in 2023, then surged by 34.16% in 2025.
  • Alkermes' Common Equity (Quarterly) stood at $1.1 billion in 2021, then fell by 6.19% to $1.0 billion in 2022, then rose by 15.23% to $1.2 billion in 2023, then climbed by 21.81% to $1.5 billion in 2024, then spiked by 34.16% to $1.7 billion in 2025.
  • Its Common Equity was $1.7 billion in Q3 2025, compared to $1.6 billion in Q2 2025 and $1.5 billion in Q1 2025.